MTCH vs ZYME · P/E 13, rev $3.48B vs rev $76.3M
Match Group Inc (MTCH) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported MTCH revenue for 2024-12-31 was $3.48B. Net income was $551.3M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
MTCH currently screens at market cap $8.24B and trailing P/E 13.5. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the MTCH and ZYME stock pages for the full models.
Not investment advice.